_id
6914891eccc777a4e85d9833
Ticker
OSTX
Name
OS Therapies Incorporated
Exchange
NYSE MKT
Address
115 Pullman Crossing Road, Grasonville, MD, United States, 21638
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://ostherapies.com
Description
OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide linker technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. OS Therapies Incorporated was incorporated in 2018 and is based in Grasonville, Maryland.
Last Close
1.49
Volume
366006
Current Price
1.455
Change
0.1
Last Updated
2026-01-06T08:44:20.072Z
Image
data:image/webp;base64,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
Ipo Date
2024-08-01T00:00:00.000Z
Market Cap
47187232
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4.75
Target Price
11.488
Strong Buy
3
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
124938
Gross Profit
-124938
Operating Expenses
6754657
Operating Income
-6879595
Interest Expense
0
Pretax Income
-6879530
Net Income
-6879530
Eps
-0.2152767029722669
Dividends Per Share
-
Shares Outstanding
35214352
Income Tax Expense
-
EBITDA
-6754592
Operating Margin
-
Total Other Income Expense Net
65
Cash
1876626
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
2321691
Property Plant Equipment
3185
Total Assets
8953251
Payables
3374287
Short Term Debt
-
Long Term Debt
-
Total Liabilities
4245351
Equity
4707900
Bs_currency_symbol
USD
Depreciation
238033791
Change In Working Capital
1036067
Cash From Operations
-4706192
Capital Expenditures
466423
Cash From Investing
-465956577
Cash From Financing
3780805
Net Change In Cash
-925387
Cf_currency_symbol
USD
PE
-
PB
9.876373357547951
ROE
-146.12736039423098
ROA
-76.83834620519406
FCF
-5172615
Fcf Percent
-
Piotroski FScore
1
Health Score
31
Deep Value Investing Score
2
Defensive Investing Score
5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.3
Garp Investing Score
1.5
Growth Investing Score
0.5
Momentum Investing Score
4.5
Net Net Investing Score
2.5
Quality Investing Score
2
Value Investing Score
2.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
124938
Quarters > 0 > income Statement > gross Profit
-124938
Quarters > 0 > income Statement > operating Expenses
6754657
Quarters > 0 > income Statement > operating Income
-6879595
Quarters > 0 > income Statement > interest Expense
0
Quarters > 0 > income Statement > pretax Income
-6879530
Quarters > 0 > income Statement > net Income
-6879530
Quarters > 0 > income Statement > eps
-0.2152767029722669
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
31956686
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-6754592
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
65
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
1876626
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
2321691
Quarters > 0 > balance Sheet > property Plant Equipment
3185
Quarters > 0 > balance Sheet > total Assets
8953251
Quarters > 0 > balance Sheet > payables
3374287
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
4245351
Quarters > 0 > balance Sheet > equity
4707900
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-6879530
Quarters > 0 > cash Flow > depreciation
238033791
Quarters > 0 > cash Flow > change In Working Capital
1036067
Quarters > 0 > cash Flow > cash From Operations
-4706192
Quarters > 0 > cash Flow > capital Expenditures
466423
Quarters > 0 > cash Flow > cash From Investing
-465956577
Quarters > 0 > cash Flow > cash From Financing
3780805
Quarters > 0 > cash Flow > net Change In Cash
-925387
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.2152767029722669
Quarters > 0 > ratios > PB
9.876373357547951
Quarters > 0 > ratios > ROE
-146.12736039423098
Quarters > 0 > ratios > ROA
-76.83834620519406
Quarters > 0 > ratios > FCF
-5172615
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
31
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
112514
Quarters > 1 > income Statement > gross Profit
-112514
Quarters > 1 > income Statement > operating Expenses
4726214
Quarters > 1 > income Statement > operating Income
-4838728
Quarters > 1 > income Statement > interest Expense
0
Quarters > 1 > income Statement > pretax Income
-4536622
Quarters > 1 > income Statement > net Income
-4536622
Quarters > 1 > income Statement > eps
-0.18063784767819016
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
25114460
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-4424108
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
302106
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
2802013
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
3553976
Quarters > 1 > balance Sheet > property Plant Equipment
3880
Quarters > 1 > balance Sheet > total Assets
10310475
Quarters > 1 > balance Sheet > payables
2702724
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
3558034
Quarters > 1 > balance Sheet > equity
6752441
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-4536622
Quarters > 1 > cash Flow > depreciation
112514
Quarters > 1 > cash Flow > change In Working Capital
1450714
Quarters > 1 > cash Flow > cash From Operations
-2360254
Quarters > 1 > cash Flow > capital Expenditures
316423
Quarters > 1 > cash Flow > cash From Investing
-292787
Quarters > 1 > cash Flow > cash From Financing
2484047
Quarters > 1 > cash Flow > net Change In Cash
-168994
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.18063784767819016
Quarters > 1 > ratios > PB
5.41160438128967
Quarters > 1 > ratios > ROE
-67.18491875752784
Quarters > 1 > ratios > ROA
-44.00012608536464
Quarters > 1 > ratios > FCF
-2676677
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
34
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
695
Quarters > 2 > income Statement > gross Profit
-695
Quarters > 2 > income Statement > operating Expenses
4998791
Quarters > 2 > income Statement > operating Income
-4999486
Quarters > 2 > income Statement > interest Expense
0
Quarters > 2 > income Statement > pretax Income
-3876859
Quarters > 2 > income Statement > net Income
-3876859
Quarters > 2 > income Statement > eps
-0.1824453774580138
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
21249423
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-3876164
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
1122627
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
2971007
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
23636
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
4095356
Quarters > 2 > balance Sheet > property Plant Equipment
4575
Quarters > 2 > balance Sheet > total Assets
4249931
Quarters > 2 > balance Sheet > payables
1616390
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
3636265
Quarters > 2 > balance Sheet > equity
613666
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-3876859
Quarters > 2 > cash Flow > depreciation
695
Quarters > 2 > cash Flow > change In Working Capital
-299265
Quarters > 2 > cash Flow > cash From Operations
-3441884
Quarters > 2 > cash Flow > capital Expenditures
150000
Quarters > 2 > cash Flow > cash From Investing
-173636
Quarters > 2 > cash Flow > cash From Financing
1053000
Quarters > 2 > cash Flow > net Change In Cash
-2562520
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.1824453774580138
Quarters > 2 > ratios > PB
50.38230970104259
Quarters > 2 > ratios > ROE
-631.7539182552072
Quarters > 2 > ratios > ROA
-91.22169277571801
Quarters > 2 > ratios > FCF
-3591884
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
17
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
1390
Quarters > 3 > income Statement > gross Profit
-1390
Quarters > 3 > income Statement > operating Expenses
2965034
Quarters > 3 > income Statement > operating Income
-2966424
Quarters > 3 > income Statement > interest Expense
7556
Quarters > 3 > income Statement > pretax Income
-2991234
Quarters > 3 > income Statement > net Income
-2991234
Quarters > 3 > income Statement > eps
-0.024167098168994705
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
123772990
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-2982284
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-24810
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
5533527
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
5533527
Quarters > 3 > balance Sheet > property Plant Equipment
5270
Quarters > 3 > balance Sheet > total Assets
5538797
Quarters > 3 > balance Sheet > payables
1662068
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
4727310
Quarters > 3 > balance Sheet > equity
811487
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-2991234
Quarters > 3 > cash Flow > depreciation
1390
Quarters > 3 > cash Flow > change In Working Capital
313444
Quarters > 3 > cash Flow > cash From Operations
-2374577
Quarters > 3 > cash Flow > capital Expenditures
3
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
6050000
Quarters > 3 > cash Flow > net Change In Cash
3675423
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.024167098168994705
Quarters > 3 > ratios > PB
221.9255520421153
Quarters > 3 > ratios > ROE
-368.6114503374669
Quarters > 3 > ratios > ROA
-54.00512060651438
Quarters > 3 > ratios > FCF
-2374580
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
17
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
2780
Annuals > 0 > income Statement > gross Profit
-2780
Annuals > 0 > income Statement > operating Expenses
6811066
Annuals > 0 > income Statement > operating Income
-6813846
Annuals > 0 > income Statement > interest Expense
2051839
Annuals > 0 > income Statement > pretax Income
-8882938
Annuals > 0 > income Statement > net Income
-8882938
Annuals > 0 > income Statement > eps
-0.4256337881316966
Annuals > 0 > income Statement > dividends Per Share
31250000
Annuals > 0 > income Statement > shares Outstanding
20869908
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-6828316
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-2069092
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
5533527
Annuals > 0 > balance Sheet > short Term Investments
5527993473
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
5533527
Annuals > 0 > balance Sheet > property Plant Equipment
5270
Annuals > 0 > balance Sheet > total Assets
5538797
Annuals > 0 > balance Sheet > payables
1662068
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
4727310
Annuals > 0 > balance Sheet > equity
811487
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-8882938
Annuals > 0 > cash Flow > depreciation
2780
Annuals > 0 > cash Flow > change In Working Capital
-129639
Annuals > 0 > cash Flow > cash From Operations
-7282295
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
12776840
Annuals > 0 > cash Flow > net Change In Cash
5494545
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-0.4256337881316966
Annuals > 0 > ratios > PB
37.03407142689901
Annuals > 0 > ratios > ROE
-1094.6494521785314
Annuals > 0 > ratios > ROA
-160.37666662995593
Annuals > 0 > ratios > FCF
-7282295
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
8
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
4220
Annuals > 1 > income Statement > gross Profit
-4220
Annuals > 1 > income Statement > operating Expenses
4342647
Annuals > 1 > income Statement > operating Income
-4342647
Annuals > 1 > income Statement > interest Expense
3448939
Annuals > 1 > income Statement > pretax Income
-7791584
Annuals > 1 > income Statement > net Income
-7791584
Annuals > 1 > income Statement > eps
-0.3886143676786458
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
20049655
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-4338425
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-3448937
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
38982
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
790032
Annuals > 1 > balance Sheet > property Plant Equipment
8050
Annuals > 1 > balance Sheet > total Assets
798082
Annuals > 1 > balance Sheet > payables
2715399
Annuals > 1 > balance Sheet > short Term Debt
14610341
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
24814297
Annuals > 1 > balance Sheet > equity
-24016215
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-7791584
Annuals > 1 > cash Flow > depreciation
4220
Annuals > 1 > cash Flow > change In Working Capital
2017250
Annuals > 1 > cash Flow > cash From Operations
-3006967
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
1145
Annuals > 1 > cash Flow > cash From Financing
2873324
Annuals > 1 > cash Flow > net Change In Cash
-132498
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.3886143676786458
Annuals > 1 > ratios > PB
-1.202167085862614
Annuals > 1 > ratios > ROE
32.44301402198473
Annuals > 1 > ratios > ROA
-976.2886520432737
Annuals > 1 > ratios > FCF
-3006967
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
805
Annuals > 2 > income Statement > gross Profit
-805
Annuals > 2 > income Statement > operating Expenses
4446299
Annuals > 2 > income Statement > operating Income
-4446299
Annuals > 2 > income Statement > interest Expense
1808386
Annuals > 2 > income Statement > pretax Income
-6254685
Annuals > 2 > income Statement > net Income
-6254685
Annuals > 2 > income Statement > eps
-0.2707559848852112
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
23100819
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-4445494
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-1808386
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
171480
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
1145
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
496835
Annuals > 2 > balance Sheet > property Plant Equipment
12270
Annuals > 2 > balance Sheet > total Assets
509105
Annuals > 2 > balance Sheet > payables
1225134
Annuals > 2 > balance Sheet > short Term Debt
3039054
Annuals > 2 > balance Sheet > long Term Debt
10347632
Annuals > 2 > balance Sheet > total Liabilities
18066333
Annuals > 2 > balance Sheet > equity
-17557228
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-6254685
Annuals > 2 > cash Flow > depreciation
805
Annuals > 2 > cash Flow > change In Working Capital
947330
Annuals > 2 > cash Flow > cash From Operations
-3792580
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
230881
Annuals > 2 > cash Flow > cash From Financing
3652391
Annuals > 2 > cash Flow > net Change In Cash
90692
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.2707559848852112
Annuals > 2 > ratios > PB
-1.894671491422222
Annuals > 2 > ratios > ROE
35.62455872874693
Annuals > 2 > ratios > ROA
-1228.5648343661917
Annuals > 2 > ratios > FCF
-3792580
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
1159642
Annuals > 3 > income Statement > gross Profit
-1159642
Annuals > 3 > income Statement > operating Expenses
3677713
Annuals > 3 > income Statement > operating Income
-4837355
Annuals > 3 > income Statement > interest Expense
2582893
Annuals > 3 > income Statement > pretax Income
-7420248
Annuals > 3 > income Statement > net Income
-7420248
Annuals > 3 > income Statement > eps
-0.3212114687362383
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
23100819
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-4836550
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-2582893
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
80788
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
231071
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
312815
Annuals > 3 > balance Sheet > property Plant Equipment
13076
Annuals > 3 > balance Sheet > total Assets
325891
Annuals > 3 > balance Sheet > payables
856521
Annuals > 3 > balance Sheet > short Term Debt
1612054000
Annuals > 3 > balance Sheet > long Term Debt
7072415
Annuals > 3 > balance Sheet > total Liabilities
11777104
Annuals > 3 > balance Sheet > equity
-11451213
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-7420248
Annuals > 3 > cash Flow > depreciation
805
Annuals > 3 > cash Flow > change In Working Capital
574668
Annuals > 3 > cash Flow > cash From Operations
-4402811
Annuals > 3 > cash Flow > capital Expenditures
11934
Annuals > 3 > cash Flow > cash From Investing
200473
Annuals > 3 > cash Flow > cash From Financing
3050350
Annuals > 3 > cash Flow > net Change In Cash
-1151988
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.3212114687362383
Annuals > 3 > ratios > PB
-2.9049480923985955
Annuals > 3 > ratios > ROE
64.7987946779088
Annuals > 3 > ratios > ROA
-2276.910991711953
Annuals > 3 > ratios > FCF
-4414745
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
30
Valuation > metrics > PE
-0.2152767029722669
Valuation > metrics > PB
9.876373357547951
Valuation > final Score
20
Valuation > verdict
229.2% Overvalued
Profitability > metrics > ROE
-146.12736039423098
Profitability > metrics > ROA
-296.31548728922155
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.901750461989422
Risk > metrics > Interest Coverage
-55.064071779602685
Risk > final Score
-172
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.6880538021810237
Liquidity > metrics > Quick Ratio
0.6880538021810237
Liquidity > final Score
44
Liquidity > verdict
Weak
Prev Valuations > 0
25.883956187103305
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
-124
Prev Risks > 1
-28768
Prev Risks > 2
-1564
Prev Liquidities > 0
83
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:21:41.389Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-17
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.21
Earnings History > 0 > eps Estimate
-0.1225
Earnings History > 0 > eps Difference
-0.0875
Earnings History > 0 > surprise Percent
-71.4286
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-18
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.18
Earnings History > 1 > eps Estimate
-0.1167
Earnings History > 1 > eps Difference
-0.0633
Earnings History > 1 > surprise Percent
-54.2416
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-15
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.18
Earnings History > 2 > eps Estimate
-0.0867
Earnings History > 2 > eps Difference
-0.0933
Earnings History > 2 > surprise Percent
-107.6125
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-31
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.19
Earnings History > 3 > eps Estimate
-0.14
Earnings History > 3 > eps Difference
-0.05
Earnings History > 3 > surprise Percent
-35.7143
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-15
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.18
Earnings History > 4 > eps Estimate
-0.08
Earnings History > 4 > eps Difference
-0.1
Earnings History > 4 > surprise Percent
-125
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-28
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.61
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide linker technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. OS Therapies Incorporated was incorporated in 2018 and is based in Grasonville, Maryland.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AIs OSTX a good stock for dollar cost averaging - Quarterly Risk Review & Fast Entry and Exit Trade Plans bollywoodhelpline.com
Read more →OS Therapies Incorporated (NYSEAMERICAN:OSTX) Sees Large Growth in Short Interest - MarketBeat
1/16/2026
OS Therapies Incorporated (NYSEAMERICAN:OSTX) Sees Large Growth in Short Interest MarketBeat
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$11.488
Analyst Picks
Strong Buy
3
Buy
1
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of OS Therapies Incorporated
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.21
EPS Estimate
-0.1225
EPS Difference
-0.0875
Surprise Percent
-71.4286%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.